Porter Novelli NV

LobbyFacts currently only presents data from the EU lobby transparency register up to 19 September 2021. This is due to recent changes made by the EU register; we are working to present these on LobbyFacts as soon as possible.

Tweet this page
How to read and use this data card.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

1,250,000€ - 1,499,999€

Financial year: 01/01/2020 - 01/12/2020

Lobbyists declared: 5.5 FTE (9)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 0

Meetings with European Commission: 0

Lobbying costs over the years:


Porter Novelli NV

Registration on EU Transparency Register

140115237045-63 (First registered: 21 Jan 2020)

Goals / Remit

Porter Novelli is an award-winning, global purpose communications consultancy with more than 45 years’ experience and 100 offices across 60 countries. Our Brussels office is the main European hub for Porter Novelli’s international client work. With more than 25 multinational and multilingual communication professionals, we specialise in providing policy communications, public affairs, advocacy, strategic communications and reputation management services for our European and international clients. As a fully integrated global team, we offer the experience and expertise of our consultants worldwide.


The client base of Porter Novelli Brussels includes companies, associations and not-for profit organisations. We advise organisations mainly from the Health & Life Sciences and Agriculture & Food sectors. We follow specific EU legislative proposals and/or policies varying according to the interests of our clients. The topics of interest include: Rare Diseases, Cancer, Biosimilars, Medicine Shortages, Supply Chains, Medicines Pricing and Quality, Pharmaceutical Strategy, Orphan Medicines Regulation, Clinical Trials, Data Policy, GDPR, Pharmacovigilance, Social Policy, Vaccines, Digital Health, Medical Devices, Nutrition Strategy, CAP Reform, Circular Economy, Food Safety and Food Quality, Green Deal related measures, Farm to Fork Strategy, Integrated Pest Management, Novel Foods, REACH, RoHS, Renewables Policy.


Head office:
Rue de l'Escaut 122
Brussels 1080

Tel: 32 4130340